Results 21 to 30 of about 569,433 (400)

SARS-CoV-2–related outcomes after surgical procedures on SARS-CoV-2–positive patients in a large, urban, safety net medical center

Surgery Open Science, 2021
Background: Beginning on March 16, 2020, nonurgent scheduled operations at a large, urban, safety net medical center were canceled. The purpose of this study was to determine complications associated with severe acute respiratory syndrome coronavirus 2 ...
Rachel E. Sargent, MD, Stephen F. Sener, MD, FACS, Rodolfo Amaya, MD, Elizabeth Vazquez, BA, Michael E. Bowdish, MD, MS, FACS, Brad Spellberg, MD   +5 more
doaj   +1 more source

Acute Blindness as a Complication of Severe Acute Respiratory Syndrome Coronavirus-2 [PDF]

Cureus, 2021
Several neurological manifestations can occur in the acute phase or in post-infection severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In certain cases, they can even reveal the disease. Although some may be consequences of direct cellular viral invasion, many represent post-infectious inflammation mediated by autoimmune mechanisms.
Fatima Zahra Mabrouki, Yassine Mebrouk, Rachid Sekhsoukh, Faiza Aziouaz   +3 more
openaire   +3 more sources

Epigallocatechin gallate (EGCG) attenuates severe acute respiratory coronavirus disease 2 (SARS-CoV-2) infection by blocking the interaction of SARS-CoV-2 spike protein receptor-binding domain to human angiotensin-converting enzyme 2

PLoS ONE, 2022
The outbreak of the coronavirus disease 2019 caused by the severe acute respiratory syndrome coronavirus 2 triggered a global pandemic where control is needed through therapeutic and preventive interventions. This study aims to identify natural compounds
Tomokazu Ohishi, Takayuki Hishiki, Mirza S. Baig, Sajjan Rajpoot, Uzma Saqib, Tomohiko Takasaki, Yukihiko Hara   +6 more
doaj   +2 more sources

False-positive detection of IgM anti-severe acute respiratory syndrome coronavirus 2 antibodies in patients with rheumatoid arthritis: Possible effects of IgM or IgG rheumatoid factors on immunochromatographic assay results

SAGE Open Medicine, 2022
Objectives: The severe acute respiratory syndrome coronavirus 2 causes coronavirus disease 2019. A serological test is conducted to determine prior infection by severe acute respiratory syndrome coronavirus 2.
Shomi Oka, Takashi Higuchi, Hiroshi Furukawa, Kota Shimada, Atsushi Hashimoto, Toshihiro Matsui, Shigeto Tohma   +6 more
doaj   +1 more source

Determining Cause of Death During Coronavirus Disease 2019 Pandemic

Critical Care Explorations, 2021
Objectives:. Controversy exists whether the cause of death due to severe acute respiratory syndrome coronavirus 2 is directly related to the infection or to underlying conditions.
Khaled M. Nada, MD, En-shuo Hsu, MS, Justin Seashore, MD, Mohammed Zaidan, MD, Shawn P. Nishi, MD, Alexander Duarte, MD, Gulshan Sharma, MD, MPH   +6 more
doaj   +1 more source

Review on development of potential inhibitors of SARS-CoV-2 main protease (MPro)

Future Journal of Pharmaceutical Sciences, 2022
Background The etiological agent for the coronavirus illness outbreak in 2019–2020 is a novel coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (COVID-19), whereas coronavirus disease pandemic of 2019 (COVID-19) has ...
Soumya Gulab Katre, Alpana Jagdish Asnani, Kumar Pratyush, Nilima Gangadhar Sakharkar, Ashwini Gajanan Bhope, Kanchan Tekram Sawarkar, Vaibhav Santosh Nimbekar   +6 more
doaj   +1 more source

Respiratory sampling for severe acute respiratory syndrome coronavirus 2: An Overview [PDF]

Head & Neck, 2020
AbstractThe novel coronavirus disease 2019 is caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) and was declared a pandemic in March 2020. A plethora of respiratory sampling methods for SARS‐CoV‐2 viral detection has been used and in the current evolving situation, there is no international consensus on the recommended method ...
See, Anna, Toh, Song Tar
openaire   +3 more sources

Confirmed severe acute respiratory syndrome coronavirus 2 encephalitis in cerebrospinal fluid: a case report

Journal of Medical Case Reports, 2022
Background Patients with severe acute respiratory syndrome coronavirus 2 infection show various clinical manifestations, including neurological .
Triana Ayuningtyas, Ronald Irwanto Natadidjaja, Chyntia Octaviani, Felly Sahli, Hadianti Adlani   +4 more
doaj   +1 more source

Role of Eyes and Eyes Protection Amidst SARS-CoV-2 Infection

Journal of Nepal Medical Association, 2021
Severe Acute Respiratory Syndrome Coronavirus 2 pandemic has infected millions of people. The conjunctival epithelium is easily exposed to infectious droplets and body fluids making eyes a potential route and reservoir of the infection.
Bibechan Thapa
doaj   +1 more source

A Comprehensive Review of Severe Acute Respiratory Syndrome Coronavirus 2 [PDF]

Cureus, 2020
Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), the virus strain that causes coronavirus disease 2019 (COVID-19), was first identified in Wuhan, China in December 2019. It spread to several countries across continents and infected more than one million people within three months. While there is no consensus on the treatment of the disease
Robert Hage, Ahmed Mahgoub, Soo-Yeon Sohn, Woong Kee Baek   +3 more
openaire   +3 more sources